These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2058394)

  • 21. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome.
    Mauras N; Merimee T; Rogol AD
    Metabolism; 1991 Oct; 40(10):1106-11. PubMed ID: 1719338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting and monitoring of growth in children with short stature during the first year of growth hormone treatment.
    Mortensen HB; Main K; Michaelsen KF; Kastrup KW; Jłrgensen JT; Skakkebaek NE
    Acta Paediatr Scand; 1991 Dec; 80(12):1150-7. PubMed ID: 1785287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
    Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
    Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G; Neuer K; Ranke MB; Wittekindt NE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
    Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
    Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.
    Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children.
    Achermann JC; Brook CG; Robinson IC; Matthews DR; Hindmarsh PC
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):301-8. PubMed ID: 10435054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective growth hormone (GH) secretion and short-term treatment in Noonan syndrome.
    Soliman AT; Rajab A; el Zalabany M; alSalmi I; Fattah MA
    Indian J Pediatr; 1998; 65(5):741-9. PubMed ID: 10773931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC; Kwan EY; Lim YJ; Lee AC; Tam CF; Lam KS
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth.
    Soliman AT; elZalabany MM; Mazloum Y; Bedair SM; Ragab MS; Rogol AD; Ansari BM
    J Trop Pediatr; 1999 Dec; 45(6):327-37. PubMed ID: 10667001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linear growth response to exogenous growth hormone in children with short stature.
    Schwartz ID; Hu CS; Shulman DI; Root AW; Bercu BB
    Am J Dis Child; 1990 Oct; 144(10):1092-7. PubMed ID: 2403090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of growth hormone on the low level of growth hormone binding protein in idiopathic short stature.
    Fontoura M; Mugnier E; Brauner R; Rappaport R; Postel-Vinay MC
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):249-53. PubMed ID: 1424207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.